Mutations occurring at the codons 600 of BRAF and 61 of RAS genes are common in human thyroid tumors, with these mutations being the most frequent events that lead to the activation of MAPK- and mTOR-signaling pathways. The gene discussed is BRAF; the disease is thyroid tumor.